[Impact of serum uric acid level on the cardiovascular system as a risk factor].
hisatome@med.tottori-u.ac.jp
Ichiro
I
Hisatome
D054392:Adipokines / Q000378:metabolism; D001553:Benzbromarone / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology*; D033461:Hyperuricemia / Q000150:complications* / Q000188:drug therapy; D007668:Kidney / Q000378:metabolism; D027361:Organic Anion Transporters / Q000502:physiology*; D027701:Organic Cation Transport Proteins / Q000502:physiology*; D010084:Oxidation-Reduction; D011339:Probenecid / Q000627:therapeutic use; D015499:Renal Tubular Transport, Inborn Errors / Q000150:complications; D012307:Risk Factors; D014527:Uric Acid / Q000378:metabolism; D014528:Uricosuric Agents / Q000627:therapeutic use; D014545:Urinary Calculi / Q000150:complications
D054392:Adipokines; D027361:Organic Anion Transporters; D027701:Organic Cation Transport Proteins; C491241:SLC22A12 protein, human; D014528:Uricosuric Agents; D014527:Uric Acid; D001553:Benzbromarone; D011339:Probenecid